Skip to Main Content

Paper Details

Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
Am J Gastroenterol
10
2022
Crohn's disease, IBD, Inflammatory Bowel Diseases, Obesity, Patients, TNF, TNF-?, inflammatory bowel diseases, obese, obesity, overweight, patient, patients, tumor necrosis factor, ulcerative colitis, ustekinumab, visceral obesity
Biological Products, Cohort Studies, Colitis, Ulcerative, Crohn Disease, Hospitalization, Humans, Inflammatory Bowel Diseases, Infliximab, Obesity, Overweight, Retrospective Studies, Tumor Necrosis Factor Inhibitors, Tumor Necrosis Factor-alpha, Ustekinumab
Author NameAffiliation
Phillip Gu
Jiyu Luouniversity of california san diego
Jihoon Kimuniversity of california san diego
Paulina Pauluniversity of california san diego
Berkeley N Limketkaiuniversity of california los angeles
Jenny Saukuniversity of california los angeles
Sunhee Park
Nimisha K Parekh
Kai Zheng
Vivek A Rudrapatna
Gaurav Syal
Christina Ha
Dermot P B McGovern
Dermot P B McGovern
Gil Y Melmed
Phillip Fleshner
Samuel Eisensteinuniversity of california san diego
Sonia Ramamoorthyuniversity of california san diego
Sonia Ramamoorthyuniversity of california san diego
Parambir S Dulaiuniversity of california san diego
Brigid S Bolanduniversity of california san diego
Brigid S Bolanduniversity of california san diego
Eduardo Grunvalduniversity of california san diego
Uma Mahadevan
Lucila Ohno-Machadouniversity of california san diego
Lucila Ohno-Machadouniversity of california san diego
William J Sandbornuniversity of california san diego
Siddharth Singhuniversity of california san diego
Siddharth Singhuniversity of california san diego
  • 1 - 29

Datasets

Release 1.2